{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:05:19Z","timestamp":1785942319020,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016062","name":"Metakids Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ymgme.2024.108542","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T02:36:56Z","timestamp":1721356616000},"page":"108542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extending diagnostic practices in gyrate atrophy: Enzymatic characterization and the development of an in vitro pyridoxine responsiveness assay"],"prefix":"10.1016","volume":"143","author":[{"given":"Berith M.","family":"Balfoort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioena","family":"Pampalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos P.N.","family":"Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone W.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion M.","family":"Brands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrie","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet A.E.M.","family":"Wagenmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.A.","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara D.","family":"van Karnebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riekelt H.","family":"Houtkooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Ferdinandusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2024.108542_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140555","article-title":"Deficit of human ornithine aminotransferase in gyrate atrophy: molecular, cellular, and clinical aspects","volume":"1869","author":"Montioli","year":"2021","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ymgme.2024.108542_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2021.695205","article-title":"Molecular and cellular studies reveal folding defects of human ornithine aminotransferase variants associated with gyrate atrophy of the choroid and retina","volume":"8","author":"Montioli","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymgme.2024.108542_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10930-017-9710-5","article-title":"Oligomeric state and thermal stability of Apo- and Holo- human ornithine \u03b4-aminotransferase","volume":"36","author":"Montioli","year":"2017","journal-title":"Protein J."},{"key":"10.1016\/j.ymgme.2024.108542_bb0020","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.bbadis.2018.08.032","article-title":"Molecular and cellular basis of ornithine \u03b4-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina","volume":"1864","author":"Montioli","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.ymgme.2024.108542_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2008.12.010","article-title":"Secondary creatine deficiency in ornithine delta-aminotransferase deficiency","volume":"97","author":"Valayannopoulos","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108542_bb0030","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1172\/JCI109905","article-title":"Gyrate atrophy of the choroid and retina with hyperornithinemia. Deficient formation of guanidinoacetic acid from arginine","volume":"66","author":"Sipila","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2024.108542_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymgme.2021.07.010","article-title":"A review of treatment modalities in gyrate atrophy of the choroid and retina (GACR)","volume":"134","author":"Balfoort","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108542_bb0040","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1177\/11206721211067333","article-title":"Gyrate atrophy of the choroid and retina: a review","volume":"32","author":"Elnahry","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2024.108542_bb0045","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"The Hyperornithinemias","author":"Valle","year":"2019"},{"key":"10.1016\/j.ymgme.2024.108542_bb0050","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/S0021-9258(19)50731-1","article-title":"Ornithine \u03b4-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences","volume":"267","author":"Brody","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2024.108542_bb0055","first-page":"616","article-title":"Pyridoxine-responsive gyrate atrophy of the choroid and retina: clinical and biochemical correlates of the mutation A226V","volume":"56","author":"Michaud","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2024.108542_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2021.695205","article-title":"Molecular and cellular studies reveal folding defects of human ornithine aminotransferase variants associated with gyrate atrophy of the choroid and retina","volume":"8","author":"Montioli","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymgme.2024.108542_bb0065","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1111\/febs.14843","article-title":"R180T variant of \u03b4-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-ray and NMR studies provide insight into its catalytic features","volume":"286","author":"Montioli","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgme.2024.108542_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1620\/tjem.205.335","article-title":"Vitamin B6-responsive ornithine aminotransferase deficiency with a novel mutation G237D","volume":"205","author":"Ohkubo","year":"2005","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ymgme.2024.108542_bb0075","author":"GM06330"},{"key":"10.1016\/j.ymgme.2024.108542_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj2530481","article-title":"5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase","volume":"253","author":"Daune","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2024.108542_bb0085","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/bjo.65.7.478","article-title":"Gyrate atrophy with hyperornithinaemia: different types of responsiveness to vitamin B6","volume":"65","author":"Hayasaka","year":"1981","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2024.108542_bb0090","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.85.11.3777","article-title":"Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy","volume":"85","author":"Ramesh","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2024.108542_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/jmbi.1997.1583","article-title":"Crystal structure of human recombinant ornithine aminotransferase","volume":"277","author":"Shen","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2024.108542_bb0100","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bbadis.2013.04.010","article-title":"Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1","volume":"1832","author":"Fargue","year":"2013","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.ymgme.2024.108542_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpn.2022.04.011","article-title":"A vitamin a day keeps the doctor away: the need for high quality pyridoxal-5\u2032-phosphate","volume":"39","author":"Stolwijk","year":"2022","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2024.108542_bb0110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nmd.2007.09.009","article-title":"Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6","volume":"18","author":"Gdynia","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2024.108542_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tiv.2017.07.009","article-title":"The vitamin B6 paradox: supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function","volume":"44","author":"Vrolijk","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ymgme.2024.108542_bb0120","series-title":"Tolerable upper intake levels for vitamins and minerals","author":"European Commission. Scientific Committee on Food","year":"2006"},{"key":"10.1016\/j.ymgme.2024.108542_bb0125","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ajcn\/87.5.1446","article-title":"Plasma pyridoxal 5\u2032-phosphate in the US population: the National Health and nutrition examination survey, 2003-2004","volume":"87","author":"Morris","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2024.108542_bb0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clinbiochem.2013.11.021","article-title":"The chaperone role of the pyridoxal 5\u2032-phosphate and its implications for rare diseases involving B6-dependent enzymes","volume":"47","author":"Cellini","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2024.108542_bb0135","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.52586\/5056","article-title":"Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach","volume":"26","author":"Pampalone","year":"2021","journal-title":"Frontiers in Bioscience - Landmark"},{"key":"10.1016\/j.ymgme.2024.108542_bb0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1010319001722","article-title":"The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders","volume":"24","author":"Gregersen","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2024.108542_bb0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.braindev.2023.02.004","article-title":"Chaperone therapy for lysosomal and non-lysosomal protein misfolding diseases","volume":"45","author":"Suzuki","year":"2023","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2024.108542_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/pnasnexus\/pgad043","article-title":"The first genetic landscape of inherited retinal dystrophies in Portuguese patients identifies recurrent homozygous mutations as a frequent cause of pathogenesis","volume":"2","author":"Peter","year":"2023","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.ymgme.2024.108542_bb0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5582\/irdr.2021.01042","article-title":"The coincidence of two ultra-rare hereditary eye diseases: gyrate atrophy and Kjer optic atrophy - a surprising diagnosis based on next-generation sequencing","volume":"10","author":"Skorczyk-Werner","year":"2021","journal-title":"Intractable Rare Dis Res"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T02:20:02Z","timestamp":1742437202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224004268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1096719224004268"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108542","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extending diagnostic practices in gyrate atrophy: Enzymatic characterization and the development of an in vitro pyridoxine responsiveness assay","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108542"}}